{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T03:43:37Z","timestamp":1776915817275,"version":"3.51.2"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shandong Provincial Health Commission and Shandong Provincial Administration of Traditional Chinese Medicine","award":["2022-93"],"award-info":[{"award-number":["2022-93"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13690-3","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T08:21:13Z","timestamp":1741076473000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Causality of blood metabolites on hepatocellular carcinoma and cholangiocarcinoma: a metabolome-wide mendelian randomization study"],"prefix":"10.1186","volume":"25","author":[{"given":"Lin","family":"Ning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanhua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanyue","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianguang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"issue":"6","key":"13690_CR1","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","volume":"145","author":"S RIZVI","year":"2013","unstructured":"RIZVI S, GORES GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma [J]. Gastroenterology. 2013;145(6):1215\u201329.","journal-title":"Gastroenterology"},{"issue":"10127","key":"13690_CR2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A FORNER","year":"2018","unstructured":"FORNER A, REIG M. Hepatocellular carcinoma [J]. Lancet. 2018;391(10127):1301\u201314.","journal-title":"Lancet"},{"issue":"5","key":"13690_CR3","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","volume":"164","author":"TOH M R","year":"2023","unstructured":"TOH M R, WONG E Y T, WONG S H, et al. Global Epidemiology and Genetics of Hepatocellular Carcinoma [J]. Gastroenterology. 2023;164(5):766\u201382.","journal-title":"Gastroenterology"},{"key":"13690_CR4","doi-asserted-by":"crossref","unstructured":"Qurashi M, Vithayathil M, Khan SA. Epidemiology of cholangiocarcinoma[J]. Eur J Surg Oncol. 2025;51(2):107064.","DOI":"10.1016\/j.ejso.2023.107064"},{"key":"13690_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-med-090514-013832","volume":"67","author":"A MARENGO","year":"2016","unstructured":"MARENGO A, ROSSO C. Liver Cancer: connections with obesity, fatty liver, and cirrhosis [J]. Annu Rev Med. 2016;67:103\u201317.","journal-title":"Annu Rev Med"},{"issue":"3","key":"13690_CR6","doi-asserted-by":"publisher","first-page":"107327481772924","DOI":"10.1177\/1073274817729245","volume":"24","author":"EL-SERAG H","year":"2017","unstructured":"MASSARWEH N N, EL-SERAG H. B. Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma [J]. Cancer Control. 2017;24(3):1073274817729245.","journal-title":"Cancer Control"},{"issue":"21","key":"13690_CR7","doi-asserted-by":"publisher","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","volume":"27","author":"E TREFTS","year":"2017","unstructured":"TREFTS E, GANNON M. WASSERMAN D H. The liver [J]. Curr Biol. 2017;27(21):R1147\u201351.","journal-title":"Curr Biol"},{"issue":"9","key":"13690_CR8","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41568-021-00383-9","volume":"21","author":"X LI","year":"2021","unstructured":"LI X, RAMADORI P. The immunological and metabolic landscape in primary and metastatic liver cancer [J]. Nat Rev Cancer. 2021;21(9):541\u201357.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"13690_CR9","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jhep.2022.04.038","volume":"77","author":"C RAGGI","year":"2022","unstructured":"RAGGI C, TADDEI M L, RAE C, et al. Metabolic reprogramming in cholangiocarcinoma [J]. J Hepatol. 2022;77(3):849\u201364.","journal-title":"J Hepatol"},{"issue":"2","key":"13690_CR10","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/hep.30319","volume":"70","author":"JM BANALES","year":"2019","unstructured":"BANALES JM, I\u00f1ARRAIRAEGUI M, ARBELAIZ A, et al. Serum metabolites as diagnostic biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and primary sclerosing cholangitis [J]. Hepatology. 2019;70(2):547\u201362.","journal-title":"Hepatology"},{"issue":"8","key":"13690_CR11","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1158\/0008-5472.CAN-20-1954","volume":"81","author":"R BROADFIELD L A, DUARTE J A G, SCHMI","year":"2021","unstructured":"BROADFIELD L A, DUARTE J A G, SCHMIEDER R, et al. Fat induces glucose metabolism in Nontransformed Liver cells and promotes liver tumorigenesis [J]. Cancer Res. 2021;81(8):1988\u20132001.","journal-title":"Cancer Res"},{"issue":"1","key":"13690_CR12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/s12967-019-02138-5","volume":"17","author":"Y SUN","year":"2019","unstructured":"SUN Y, LI W. Loss of alanine-glyoxylate and serine-pyruvate aminotransferase expression accelerated the progression of hepatocellular carcinoma and predicted poor prognosis [J]. J Transl Med. 2019;17(1):390.","journal-title":"J Transl Med"},{"issue":"6","key":"13690_CR13","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.jhep.2018.08.027","volume":"69","author":"J CHAN A W H, ZHONG","year":"2018","unstructured":"CHAN A W H, ZHONG J. Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection [J]. J Hepatol. 2018;69(6):1284\u201393.","journal-title":"J Hepatol"},{"issue":"4","key":"13690_CR14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","volume":"70","author":"X ZHANG","year":"2021","unstructured":"ZHANG X, COKER O O CHUES, et al. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites [J]. Gut. 2021;70(4):761\u201374.","journal-title":"Gut"},{"issue":"4","key":"13690_CR15","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.4143\/crt.2020.817","volume":"53","author":"X MA","year":"2021","unstructured":"MA X, CUI H, SUN M, et al. Fasting blood glucose, cholesterol, and risk of primary Liver Cancer: the Kailuan study [J]. Cancer Res Treat. 2021;53(4):1113\u201322.","journal-title":"Cancer Res Treat"},{"issue":"1","key":"13690_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"I VITALE","year":"2019","unstructured":"VITALE I, MANIC G, COUSSENS L M, et al. Macrophages and metabolism in the Tumor microenvironment [J]. Cell Metab. 2019;30(1):36\u201350.","journal-title":"Cell Metab"},{"issue":"1","key":"13690_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s42255-020-00317-z","volume":"3","author":"MC ELIA I, HAIGIS","year":"2021","unstructured":"ELIA I, HAIGIS MC. Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism [J]. Nat Metab. 2021;3(1):21\u201332.","journal-title":"Nat Metab"},{"issue":"1","key":"13690_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-023-01478-6","volume":"16","author":"M LI","year":"2023","unstructured":"LI M, YANG Y, XIONG L, et al. Metabolism, metabolites, and macrophages in cancer [J]. J Hematol Oncol. 2023;16(1):80.","journal-title":"J Hematol Oncol"},{"issue":"R1","key":"13690_CR19","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"HEMANIG DAVEY SMITH G","year":"2014","unstructured":"DAVEY SMITH G HEMANIG. Mendelian randomization: genetic anchors for causal inference in epidemiological studies [J]. Hum Mol Genet. 2014;23(R1):R89\u201398.","journal-title":"Hum Mol Genet"},{"key":"13690_CR20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1146\/annurev-genom-090314-050016","volume":"16","author":"G EVANS D M, DAVEY SMITH","year":"2015","unstructured":"EVANS D M, DAVEY SMITH G. Mendelian randomization: New Applications in the coming age of hypothesis-free causality [J]. Annu Rev Genomics Hum Genet. 2015;16:327\u201350.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"13690_CR21","doi-asserted-by":"crossref","unstructured":"VISSCHER P M, BROWN M A, MCCARTHY M I et al. Five years of GWAS discovery [J]. Am J Hum Genet. 2012, 90(1).","DOI":"10.1016\/j.ajhg.2011.11.029"},{"issue":"1","key":"13690_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12916-021-02193-0","volume":"20","author":"E BOURAS","year":"2022","unstructured":"BOURAS E, KARHUNEN V. Circulating inflammatory cytokines and risk of five cancers: a mendelian randomization analysis [J]. BMC Med. 2022;20(1):3.","journal-title":"BMC Med"},{"issue":"1","key":"13690_CR23","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1186\/s12889-023-15467-4","volume":"23","author":"L NING","year":"2023","unstructured":"NING L, SUN J. Associations between body circumference and testosterone levels and risk of metabolic dysfunction-associated fatty liver disease: a mendelian randomization study [J]. BMC Public Health. 2023;23(1):602.","journal-title":"BMC Public Health"},{"issue":"2","key":"13690_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1001\/jamapsychiatry.2020.3436","volume":"78","author":"N KAPPELMANN","year":"2021","unstructured":"KAPPELMANN N, ARLOTH J, GEORGAKIS M K, et al. Dissecting the Association between Inflammation, metabolic dysregulation, and specific depressive symptoms: a genetic correlation and 2-Sample mendelian randomization study [J]. JAMA Psychiatry. 2021;78(2):161\u201370.","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"13690_CR25","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s12916-020-01855-9","volume":"18","author":"N BULL C J, BELL J A, MURPHY","year":"2020","unstructured":"BULL C J, BELL J A, MURPHY N, et al. Adiposity, metabolites, and colorectal cancer risk: mendelian randomization study [J]. BMC Med. 2020;18(1):396.","journal-title":"BMC Med"},{"issue":"3","key":"13690_CR26","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/ije\/dyw127","volume":"45","author":"DA LAWLOR","year":"2016","unstructured":"LAWLOR DA, Commentary. Two-sample mendelian randomization: opportunities and challenges [J]. Int J Epidemiol. 2016;45(3):908\u201315.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"13690_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41588-022-01270-1","volume":"55","author":"Y CHEN","year":"2023","unstructured":"CHEN Y, LU T, PETTERSSON-KYMMER U, et al. Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases [J]. Nat Genet. 2023;55(1):44\u201353.","journal-title":"Nat Genet"},{"issue":"4","key":"13690_CR28","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/ng.3809","volume":"49","author":"T LONG","year":"2017","unstructured":"LONG T, HICKS M, YU, H-C, et al. Whole-genome sequencing identifies common-to-rare variants associated with human blood metabolites [J]. Nat Genet. 2017;49(4):568\u201378.","journal-title":"Nat Genet"},{"issue":"6","key":"13690_CR29","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/ng.2982","volume":"46","author":"SHIN","year":"2014","unstructured":"SHIN, S-Y, FAUMAN E B, PETERSEN A-K, et al. An atlas of genetic influences on human blood metabolites [J]. Nat Genet. 2014;46(6):543\u201350.","journal-title":"Nat Genet"},{"key":"13690_CR30","doi-asserted-by":"crossref","unstructured":"HYSI P G, MANGINO M, CHRISTOFIDOU P et al. Metabolome Genome-Wide Association Study identifies 74 novel genomic regions influencing plasma metabolites levels [J]. Metabolites, 2022. 12(1).","DOI":"10.3390\/metabo12010061"},{"issue":"10","key":"13690_CR31","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","volume":"52","author":"V ORR\u00f9","year":"2020","unstructured":"ORR\u00f9 V, STERI M. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy [J]. Nat Genet. 2020;52(10):1036\u201345.","journal-title":"Nat Genet"},{"issue":"12","key":"13690_CR32","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.joca.2021.08.003","volume":"29","author":"R YU X H, YANG Y Q, CAO R","year":"2021","unstructured":"YU X H, YANG Y Q, CAO R R, et al. The causal role of gut microbiota in development of osteoarthritis [J]. Osteoarthritis Cartilage. 2021;29(12):1741\u201350.","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"13690_CR33","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1186\/s12888-023-05081-4","volume":"23","author":"C WANG","year":"2023","unstructured":"WANG C, ZHU D, ZHANG D, et al. Causal role of immune cells in schizophrenia: mendelian randomization (MR) study [J]. BMC Psychiatry. 2023;23(1):590.","journal-title":"BMC Psychiatry"},{"key":"13690_CR34","doi-asserted-by":"publisher","first-page":"1108086","DOI":"10.3389\/fgene.2023.1108086","volume":"14","author":"Z GUO","year":"2023","unstructured":"GUO Z, ZHANG T, YUN Z, et al. Assessing the causal relationships between human blood metabolites and the risk of NAFLD: a comprehensive mendelian randomization study [J]. Front Genet. 2023;14:1108086.","journal-title":"Front Genet"},{"key":"13690_CR35","doi-asserted-by":"publisher","first-page":"905178","DOI":"10.3389\/fpubh.2022.905178","volume":"10","author":"YU","year":"2022","unstructured":"YU, X-H, CAO R-R, YANG Y-Q, et al. Systematic evaluation for the causal effects of blood metabolites on osteoporosis: genetic risk score and mendelian randomization [J]. Front Public Health. 2022;10:905178.","journal-title":"Front Public Health"},{"issue":"6588","key":"13690_CR36","doi-asserted-by":"publisher","first-page":"eabl3533","DOI":"10.1126\/science.abl3533","volume":"376","author":"S AGANEZOV","year":"2022","unstructured":"AGANEZOV S, YAN S M, SOTO D C, et al. A complete reference genome improves analysis of human genetic variation [J]. Science. 2022;376(6588):eabl3533.","journal-title":"Science"},{"issue":"1","key":"13690_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","volume":"28","author":"S BURGESS","year":"2017","unstructured":"BURGESS S, BOWDEN J, FALL T, et al. Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants [J]. Epidemiology. 2017;28(1):30\u201342.","journal-title":"Epidemiology"},{"issue":"6","key":"13690_CR38","first-page":"1961","volume":"45","author":"J BOWDEN","year":"2016","unstructured":"BOWDEN J, DEL GRECO M F, MINELLI C, et al. Assessing the suitability of summary data for two-sample mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic [J]. Int J Epidemiol. 2016;45(6):1961\u201374.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"13690_CR39","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J BOWDEN","year":"2016","unstructured":"BOWDEN J, DAVEY SMITH G, HAYCOCK P C, et al. Consistent estimation in mendelian randomization with some Invalid instruments using a weighted median estimator [J]. Genet Epidemiol. 2016;40(4):304\u201314.","journal-title":"Genet Epidemiol"},{"key":"13690_CR40","doi-asserted-by":"publisher","first-page":"987401","DOI":"10.3389\/fendo.2022.987401","volume":"13","author":"L LU","year":"2022","unstructured":"LU L, WAN B, LI L, et al. Hypothyroidism has a protective causal association with hepatocellular carcinoma: a two-sample mendelian randomization study [J]. Front Endocrinol (Lausanne). 2022;13:987401.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"13690_CR41","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/jrsm.1346","volume":"10","author":"J BOWDEN","year":"2019","unstructured":"BOWDEN J, HOLMES MV. Meta-analysis and mendelian randomization: a review [J]. Res Synth Methods. 2019;10(4):486\u201396.","journal-title":"Res Synth Methods"},{"issue":"5","key":"13690_CR42","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S BURGESS","year":"2017","unstructured":"BURGESS S, THOMPSON SG. Interpreting findings from mendelian randomization using the MR-Egger method [J]. Eur J Epidemiol. 2017;32(5):377\u201389.","journal-title":"Eur J Epidemiol"},{"issue":"10","key":"13690_CR43","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s10654-018-0424-6","volume":"33","author":"S BURGESS","year":"2018","unstructured":"BURGESS S, LABRECQUE JA. Mendelian randomization with a binary exposure variable: interpretation and presentation of causal estimates [J]. Eur J Epidemiol. 2018;33(10):947\u201352.","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"13690_CR44","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/s41467-020-14452-4","volume":"11","author":"Y CHO","year":"2020","unstructured":"CHO Y, HAYCOCK P C SANDERSONE, et al. Exploiting horizontal pleiotropy to search for causal pathways within a mendelian randomization framework [J]. Nat Commun. 2020;11(1):1010.","journal-title":"Nat Commun"},{"issue":"4","key":"13690_CR45","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41416-021-01532-5","volume":"126","author":"RK KELLEY","year":"2022","unstructured":"KELLEY RK, MIKSAD R, CICIN I, et al. Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade [J]. Br J Cancer. 2022;126(4):569\u201375.","journal-title":"Br J Cancer"},{"issue":"6","key":"13690_CR46","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.jhep.2020.07.025","volume":"73","author":"R FAN","year":"2020","unstructured":"FAN R, PAPATHEODORIDIS G, SUN J, et al. aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis [J]. J Hepatol. 2020;73(6):1368\u201378.","journal-title":"J Hepatol"},{"issue":"6","key":"13690_CR47","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1053\/j.gastro.2020.01.028","volume":"158","author":"M QIN W-H, YANG Z-S, LI","year":"2020","unstructured":"QIN W-H, YANG Z-S, LI M, et al. High serum levels of cholesterol increase Antitumor functions of Nature Killer cells and reduce growth of liver tumors in mice [J]. Gastroenterology. 2020;158(6):1713\u201327.","journal-title":"Gastroenterology"},{"issue":"5","key":"13690_CR48","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1097\/MPG.0000000000002862","volume":"71","author":"YAN Y Y","year":"2020","unstructured":"YAN Y Y, WANG M X, GONG J Y, et al. Abnormal bilirubin metabolism in patients with Sodium Taurocholate Cotransporting Polypeptide Deficiency [J]. J Pediatr Gastroenterol Nutr. 2020;71(5):e138\u201341.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"13690_CR49","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.cvsm.2022.01.003","volume":"52","author":"MICHAELH SZLOSEK","year":"2022","unstructured":"SZLOSEK MICHAELH, CLEMENTS D. Symmetrical dimethylarginine: evaluating chronic kidney disease in the era of multiple kidney biomarkers [J]. Vet Clin North Am Small Anim Pract. 2022;52(3):609\u201329.","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"13690_CR50","doi-asserted-by":"crossref","unstructured":"LIU T, YANG H, FAN W et al. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer [J]. Gastroenterology, 2018, 155(2).","DOI":"10.1053\/j.gastro.2018.04.032"},{"issue":"1","key":"13690_CR51","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1038\/s41467-021-25701-5","volume":"12","author":"HARRISON S A","year":"2021","unstructured":"HARRISON S A, GUNN N, NEFF G W, et al. A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes [J]. Nat Commun. 2021;12(1):5503.","journal-title":"Nat Commun"},{"issue":"3 Pt 1","key":"13690_CR52","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/hep.1840120307","volume":"12","author":"L GALLE P R, THEILMANN","year":"1990","unstructured":"GALLE P R, THEILMANN L, RAEDSCH R, et al. Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes [J]. Hepatology. 1990;12(3 Pt 1):486\u201391.","journal-title":"Hepatology"},{"issue":"6","key":"13690_CR53","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/hep.510280639","volume":"28","author":"GUICCIARDI M E","year":"1998","unstructured":"GUICCIARDI M E, GORES G J. Is ursodeoxycholate an antiapoptotic drug? [J]. Hepatology. 1998;28(6):1721\u20133.","journal-title":"Hepatology"},{"issue":"1","key":"13690_CR54","doi-asserted-by":"publisher","first-page":"e13424","DOI":"10.1111\/asj.13424","volume":"91","author":"T NAKANISHI","year":"2020","unstructured":"NAKANISHI T, KAGAMIZONO K, YOKOYAMA S, et al. Effects of dietary phytol on tissue accumulation of phytanic acid and pristanic acid and on the tissue lipid profiles in mice [J]. Anim Sci J. 2020;91(1):e13424.","journal-title":"Anim Sci J"},{"issue":"6","key":"13690_CR55","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0163-7827(01)00011-X","volume":"40","author":"NM VERHOEVEN","year":"2001","unstructured":"VERHOEVEN NM. Human metabolism of phytanic acid and pristanic acid [J]. Prog Lipid Res. 2001;40(6):453\u201366.","journal-title":"Prog Lipid Res"},{"issue":"10","key":"13690_CR56","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1016\/S0022-2275(20)37136-4","volume":"38","author":"VERHOEVEN N M","year":"1997","unstructured":"VERHOEVEN N M, WANDERS R J, SCHOR D S, et al. Phytanic acid alpha-oxidation: decarboxylation of 2-hydroxyphytanoyl-CoA to pristanic acid in human liver [J]. J Lipid Res. 1997;38(10):2062\u201370.","journal-title":"J Lipid Res"},{"issue":"1","key":"13690_CR57","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1053\/gast.2003.50017","volume":"124","author":"SETCHELL K D R","year":"2003","unstructured":"SETCHELL K D R, HEUBI J E, BOVE K E, et al. Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy [J]. Gastroenterology. 2003;124(1):217\u201332.","journal-title":"Gastroenterology"},{"issue":"4","key":"13690_CR58","doi-asserted-by":"publisher","first-page":"e0153672","DOI":"10.1371\/journal.pone.0153672","volume":"11","author":"I YET","year":"2016","unstructured":"YET I, MENNI C, SHIN S-Y, et al. Genetic influences on metabolite levels: a comparison across Metabolomic platforms [J]. PLoS ONE. 2016;11(4):e0153672.","journal-title":"PLoS ONE"},{"issue":"4","key":"13690_CR59","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.bmcl.2004.12.043","volume":"15","author":"JJ TURNER","year":"2005","unstructured":"TURNER JJ, HEALY J P, DOBSON R C J, et al. Two new irreversible inhibitors of dihydrodipicolinate synthase: diethyl (E,E)-4-oxo-2,5-heptadienedioate and diethyl (E)-4-oxo-2-heptenedioate [J]. Bioorg Med Chem Lett. 2005;15(4):995\u20138.","journal-title":"Bioorg Med Chem Lett"},{"issue":"8 Suppl 1","key":"13690_CR60","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/0026-0495(89)90148-0","volume":"38","author":"I MAGNUSSON","year":"1989","unstructured":"MAGNUSSON I, KIHLBERG R. Utilization of intravenously administered N-acetyl-L-glutamine in humans [J]. Metabolism. 1989;38(8 Suppl 1):82\u20138.","journal-title":"Metabolism"},{"issue":"4","key":"13690_CR61","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11306-021-01860-w","volume":"18","author":"VM PAK","year":"2022","unstructured":"PAK VM, SHI RUSSELLK. Sphinganine is associated with 24-h MAP in the non-sleepy with OSA [J]. Metabolomics. 2022;18(4):23.","journal-title":"Metabolomics"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13690-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13690-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13690-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T08:51:32Z","timestamp":1741078292000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13690-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13690"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13690-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"29 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"I ensure that my manuscript complies with the STROBE-MR guidelines for reporting Mendelian randomization studies (), and I have included the complete STROBE-MR checklist in the supplementary files.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"STROBE-MR checklist"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"389"}}